Related Experiment Video
Updated: Aug 21, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Surgical revascularization after acute myocardial infarction in patients with end-stage renal disease
Gregory D Trachiotis1, Devika Hanumara, Leanne McKenna
1Division of Cardiothoracic Surgery, The George Washington University, Veterans Affairs Medical Center, 50 Irving Street, NW Sec 112, Washington, DC 20422, USA. gtrachiotis@mfa.gwu.edu
Insights
Coronary artery bypass grafting (CABG) is a viable option for patients with end-stage renal disease (ESRD) experiencing acute myocardial infarction (AMI). Outcomes were similar to those with remote myocardial infarction, suggesting early CABG is a safe treatment strategy.
Area of Science:
- Cardiology
- Nephrology
- Cardiovascular Surgery
Background:
- Cardiovascular disease is the leading cause of death in end-stage renal disease (ESRD) patients.
- Acute myocardial infarction (AMI) in ESRD patients carries a high mortality rate and poor long-term survival.
- The efficacy of coronary artery bypass grafting (CABG) during AMI in ESRD patients is not well-defined.
Purpose of the Study:
- To evaluate the perioperative outcomes of CABG in ESRD patients who underwent the procedure during an AMI.
- To compare these outcomes with ESRD patients who had a remote myocardial infarction (RMI) at the time of CABG.
Main Methods:
- A retrospective study of 342 ESRD patients (serum creatinine >2.0mg/dl or dialysis dependence) who underwent CABG between 1995 and 2000.
- Patients were divided into two groups: those with AMI (<7 days prior to CABG) and those with RMI (>7 days prior to CABG).
- Demographic, clinical, and perioperative data were compared between the AMI and RMI groups.
Main Results:
- Patient characteristics, including age, sex, creatinine levels, and dialysis dependence, were similar between the AMI and RMI groups.
- Surgical approaches, such as multivessel CABG, off-pump CABG (OPCAB), and arterial conduit use, were comparable in both groups.
- Postoperative pulmonary complications and atrial fibrillation were more frequent in the AMI group, but hospital mortality was similar (10% vs. 8.5%, P=0.88).
Conclusions:
- ESRD patients undergoing CABG, whether for AMI or RMI, represent a high-risk population.
- Selecting patients for early CABG during AMI in the setting of ESRD appears to be a safe and viable therapeutic strategy.
- The study supports considering CABG as an early treatment option for ESRD patients experiencing AMI.
Objective:
Cardiovascular disease accounts for over 50% of deaths in patients with end-stage renal disease (ESRD). After acute myocardial infarction (AMI), hospital mortality exceeds 25%, and survival beyond 2 years is <20% for patients with ERSD. The role of coronary artery bypass grating (CABG) in the setting of an AMI in patients with ESRD remains undefined.
Methods:
Three hundred and forty-two patients had preoperative ESRD (serum creatinine >2.0mg/dl or dialysis dependence) between 1995 and 2000. One hundred and nineteen patients had an AMI (<7 days) and 223 patients had a remote myocardial infarction (RMI) (>7 days) at the time of CABG. The study group, AMI, was compared to the RMI group, which served as a comparison group.
Results:
The age (69 vs. 67 years), males (68 vs. 67%), creatinine (3.18 vs. 3.76 mg/dl, P=0.06), and preoperative dialysis (19 vs. 22%, P=0.52) were similar in either the AMI or RMI group, respectively. The frequency of diabetes, hypertension, dyslipidemia, previous myocardial infarction were common, yet not different between groups (P=NS). For either AMI or RMI group, multivessel CABG (96 vs. 94%, P=0.73), off-pump CABG (OPCAB) (22 vs. 18%, P=0.67), and arterial conduits (71 vs. 78%, P=0.42) were similar. Among postoperative events, only pulmonary complications (33.8 vs. 14.7%, P=0.049) and atrial fibrillation (48 vs. 29%, P<0.001) were more common in the AMI group. Hospital mortality was no different between the AMI and RMI groups (10 vs. 8.5%, P=0.88).
Conclusions:
Although patients with ESRD that have an AMI or RMI represent high risk groups, perioperative outcomes suggest that patients selected for CABG as an early treatment strategy in the setting of an AMI represents a viable therapeutic option.
Related Concept Videos
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant II: Surgical Procedure
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury V: Interprofessional Care
Imaging Studies VII: Vascular Imaging
